Loading Events

Erasca Virtual Investor Event Highlighting Clinical Momentum Across Its RAS-Targeting Franchise

Events Banners_2 (51)
DATE: November 20, 2026
TIME: 8:00 AM EST
LOCATION: Virtual

About The Event

Join Erasca for a virtual investor event with company management to discuss updated Phase 1 data for ERAS-0015, a potential best-in-class pan-RAS molecular glue for RAS-mutant solid tumors, and other updates.

The event will follow an oral presentation of ERAS-0015 clinical data and a poster presentation of nonclinical ERAS-0015 and ERAS-4001 combination data at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, taking place Nov. 18–20 in Barcelona, Spain.

A live question and answer session will follow the formal presentations.